Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Novel trial strategies to enhance the relevance, efficiency, effectiveness and impact of nephrology research|
|Citation:||Kidney International, 2020; 98(3):572-578|
|Kathryn Dansie, Andrea K. Viecelli, Elaine M. Pascoe, David W. Johnson, Stephen McDonald, Philip Clayton and Carmel Hawley|
|Abstract:||Randomised Controlled Trials (RCTs) are considered the gold-standard for evaluating the effectiveness of interventions. However, criticisms of traditional designs are that they can be inefficient, inflexible, expensive and conducted in a manner disconnected from real-life clinical practice. Novel strategies and approaches are being utilised to overcome these limitations including comprehensive consumer engagement, core outcome sets, novel trial designs, streamlined data collection, cost-effectiveness and return on investment evaluations, knowledge dissemination plans and impact evaluation. These strategies can be implemented at the design, conduct, implementation and dissemination stages of the trial process. This review aims to provide an overview of these strategies and approaches to improve the relevance, efficiency, effectiveness and impact of nephrology research.|
|Keywords:||chronic kidney disease|
|Rights:||© 2020, International Society of Nephrology. Published byElsevier Inc. All rights reserved.|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.